Healthcare ❯Pharmaceuticals

Drug Manufacturing

Weight Loss Drugs Active Pharmaceutical Ingredients Tariffs Sales Performance Supply Chain Active Ingredients U.S. Drug Policy Drug Investment Research and Development

Johnson & Johnson Launches $55 Billion U.S. Manufacturing and Research Expansion

Eli Lilly Announces $27 Billion Investment in U.S. Manufacturing Expansion

Johnson & Johnson Exceeds Q4 Expectations with Strong Cancer Drug Sales

Eli Lilly Names Lucas Montarce as New CFO Amid Expansion Efforts

Eli Lilly Invests $9 Billion to Boost Production of Weight Loss Drugs